Ignite Creation Date:
2025-12-24 @ 6:58 PM
Ignite Modification Date:
2025-12-29 @ 6:07 AM
Study NCT ID:
NCT05472857
Status:
RECRUITING
Last Update Posted:
2024-03-06
First Post:
2022-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
Sponsor:
Suzhou Immunofoco Biotechnology Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-08-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-12
Completion Date Type:
ESTIMATED
First Submit Date:
2022-07-20
First Submit QC Date:
None
Study First Post Date:
2022-07-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-04
Last Update Post Date:
2024-03-06
Last Update Post Date Type:
ACTUAL